Science
Mechanism of Action
As a niacin derivative, Nicotinyl Tartrate acts primarily as a vasodilator, promoting increased blood flow by relaxing vascular smooth muscles. This effect is mediated through the release of prostaglandins, particularly prostacyclin (PGI2), and nitric oxide. Beyond its circulatory impact, it contributes to lipid modulation and inhibits free fatty acid mobilization, while also functioning as a skin conditioning agent in topical formulations.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
A 1% aqueous solution of Nicotinyl Tartrate maintains stability across a pH range of 3.0 to 4.0 and is reported to be stable under conditions of heat, acidity, and alkalinity. For raw material storage, it is crucial to protect it from heat, direct light, and moisture to prevent degradation.
Safety
Safety Profile
Registered as a Drug/Therapeutic Agent with the FDA (UNII 5G605ZIE90), Nicotinyl Tartrate is known to induce a distinct cutaneous flushing, characterized by warmth and redness, particularly on the face and neck. Its use warrants caution for individuals with a history of peptic ulcers, liver disease, or gout, and should be avoided by those with known niacin allergies. Comprehensive safety data regarding its use in pregnant or breastfeeding individuals is not established.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While demonstrating vasodilatory effects, Nicotinyl Tartrate carries a significant risk of cutaneous flushing and lacks sufficient clinical efficacy data for general cosmetic use, making its inclusion questionable for broad precision skincare applications.
Related
Similar Ingredients
Finding similar ingredients…